SK Hynix Just Announced Huge News for Micron Shareholders

SK Hynix said its DRAM and high-bandwidth memory capacity is sold out through 2029, prompting the article to argue that strong AI-related memory demand and prices could persist longer and benefit Micron. Micron is expanding production with facilities scheduled to open across the U.S. and internationally in 2027–2028, while the article says its shares trade at 5 times FY2027 earnings versus a historical 20–25 times trailing earnings; a 4–5x stock rise is presented as conditional on estimates being met and valuation multiples recovering. The outlook is bullish but depends on AI demand, market conditions and investor willingness to re-rate the cyclical business.

Analysis

The key distinction is between allocated HBM capacity and durable, profitable demand across memory. A reported sell-out can reflect customer reservations or a constrained product mix; it does not establish take-or-pay commitments, pricing, yields, or equivalent demand for Micron. Verify Micron’s HBM bookings, customer qualification, and realized pricing before treating SK hynix’s outlook as transferable. The second-order risk is that today’s shortage incentivizes industry capex: Micron’s planned capacity adds support revenue only if demand and product mix absorb them without weakening pricing. A 2027–29 ramp could therefore extend the cycle—or mark the point when supply catches up.

Near term (days), the bullish narrative may support MU, but the cited 5x FY27 earnings is not a dependable floor: memory earnings are cyclical, and peak estimates can make a low multiple look misleading. The 20–25x historical comparison is not a sound re-rating anchor. Over 1–3 months, watch MU guidance, HBM customer commitments and revisions to DRAM pricing; over 6–18 months, track fab timing, yields, and whether new capacity is absorbed. AI spending efficiency, customer concentration, or a shift in accelerator demand could reverse the thesis. SK hynix’s disclosure is constructive for the sector, not proof that MU shares the same visibility or economics.

Key Decisions for Investors

• If adding exposure, build MU in stages rather than buying the claim of a multi-year shortage outright. Reassess after the next guidance update; require evidence of durable HBM orders and pricing, not just industry sell-out commentary.
• Do not underwrite a 4–5x return from a historical P/E comparison. Treat forward earnings as potentially peak-cycle and size the position for a sharp estimate or multiple reset.
• Watch for thesis failure: downward MU guidance or estimates, weakening DRAM/HBM pricing, customer order deferrals, or capacity coming online faster than demand. These would argue for reducing or avoiding the long.
• No clean relative-value trade is established by the article: SK hynix’s capacity claims do not prove MU has comparable bookings, mix, or execution. Compare company-level order visibility and ramp data before considering a MU/SK hynix pair.